Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
GMP Registry: New Certificates Issued and Refusals in January 2026
On January 26, the Ministry of Industry and Trade...
First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
High Aseptics: R-Opra Launches Complex Oncology Drug Production in Moscow
The Moscow-based R-Opra plant (part of the R-Pharm Group)...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Global Pharma 2026: USA Dictates Prices, Europe Loses Leadership, Asia Booms
The global pharmaceutical industry is entering a correction phase....
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
American-Style “Divorce”: US Officially Exits WHO, Leaving Debts and Global Risks Behind
January 22, 2026, will go down in history as...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Vet Pharma Under Digital Surveillance: “Chestny Znak” Exposes 950 Unlicensed Sellers
The Russian veterinary drug market is shifting to a...
Large-Scale Deregistration: 85 Drugs and Substances Excluded from State Register
On January 20, 2026, the Ministry of Health of...
Green Corridor for Veterinary Vaccines: Ministry of Agriculture Simplifies Market Entry
The Ministry of Agriculture of the Russian Federation has...
Important changes in the conduct of pharmaceutical inspections of veterinary manufacturers in accordance with the EAEU Rules
At the end of last year, the third version...
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
GMP Registry: New Certificates Issued and Refusals in January 2026
On January 26, the Ministry of Industry and Trade...
First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
High Aseptics: R-Opra Launches Complex Oncology Drug Production in Moscow
The Moscow-based R-Opra plant (part of the R-Pharm Group)...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Global Pharma 2026: USA Dictates Prices, Europe Loses Leadership, Asia Booms
The global pharmaceutical industry is entering a correction phase....
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
American-Style “Divorce”: US Officially Exits WHO, Leaving Debts and Global Risks Behind
January 22, 2026, will go down in history as...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Vet Pharma Under Digital Surveillance: “Chestny Znak” Exposes 950 Unlicensed Sellers
The Russian veterinary drug market is shifting to a...
Large-Scale Deregistration: 85 Drugs and Substances Excluded from State Register
On January 20, 2026, the Ministry of Health of...
Green Corridor for Veterinary Vaccines: Ministry of Agriculture Simplifies Market Entry
The Ministry of Agriculture of the Russian Federation has...
Important changes in the conduct of pharmaceutical inspections of veterinary manufacturers in accordance with the EAEU Rules
At the end of last year, the third version...
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Roche Challenges Leaders: New Drug Shows 22.5% Weight Loss in 48 Weeks
Swiss pharmaceutical giant Roche published positive Phase II results...
Battle of Brands 2025: Rise of Russian Blockbusters and Fall of Old Giants
The Russian retail pharmaceutical market, which reached a volume...
Genetico Invests 50 Million Rubles in Development of Drugs for Heart Diseases
Genetico Center (part of the Artgen Biotech group) invests...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Newsletter
Get important news delivered directly to your inbox and stay connected!